Feed Preview

Going Viral

Tau Aggregation: Genomics

Tau Aggregation: Genomics diagram by undefined

Tau Aggregation is an important characteristic in some neurodegenerative disorders, including Alzheimer’s Disease. Discover the latest research using genomics to understand Tau Aggregation.

Top 20 most recent papers
Blood

Combined Ibrutinib and Venetoclax for First-Line Treatment for Patients with Chronic Lymphocytic Leukemia (CLL)

BloodNovember 13, 2019
Nitin K JainWilliam G Wierda
1
Blood

ELEVATE TN: Phase 3 Study of Acalabrutinib Combined with Obinutuzumab (O) or Alone Vs O Plus Chlorambucil (Clb) in Patients (Pts) with Treatment-Naive Chronic Lymphocytic Leukemia (CLL)

BloodNovember 13, 2019
Jeff P SharmanJohn C. Byrd
1
Blood

Ibrutinib (Ibr) Plus Venetoclax (Ven) for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): Results from the MRD Cohort of the Phase 2 CAPTIVATE Study

BloodNovember 13, 2019
Constantine S TamWilliam G Wierda
1
Neurology

Cerebrospinal fluid dynamics disorders: Relationship to Alzheimer biomarkers and cognition

NeurologyNovember 12, 2019
Jonathan Graff-RadfordClifford R. Jack
4
1
Blood

Preliminary Safety and Efficacy Results from a Phase 2 Study of Acalabrutinib, Venetoclax and Obinutuzumab in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL)

BloodNovember 13, 2019
Benjamin L LampsonMatthew S Davids
1
Scientific Reports

Contribution of syndecans to cellular uptake and fibrillation of α-synuclein and tau

Scientific ReportsNovember 12, 2019
Anett HudákTamás Letoha
10
1
Biological Psychiatry

Propagation of Tau Pathology: Integrating Insights From Postmortem and In Vivo Studies

Biological PsychiatryOctober 3, 2019
Thomas VogelsMichael L Schöll
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine

Evaluation of dosimetry, quantitative methods and test-retest variability of 18 F-PI-2620 PET for the assessment of tau deposits in the human brain

Journal of Nuclear Medicine : Official Publication, Society of Nuclear MedicineNovember 11, 2019
Santiago BullichAndrew W Stephens
1
bioRxiv

A/T/N polygenic risk score for cognitive decline in old age

bioRxivNovember 12, 2019
Annah M. MooreTimothy J. Hohman
23
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine

Tau PET imaging with 18 F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study

Journal of Nuclear Medicine : Official Publication, Society of Nuclear MedicineNovember 11, 2019
Andre MuellerAndrew W Stephens
1
1
bioRxiv

GSK-3β regulates the synaptic expression of NMDA receptors via phosphorylation of phosphatidylinositol 4 kinase type IIα

bioRxivNovember 19, 2019
Mascia AmiciGraham Leon Collingridge
The Science of the Total Environment

Latitudes mediate the association between influenza activity and meteorological factors: A nationwide modelling analysis in 45 Japanese prefectures from 2000 to 2018

The Science of the Total EnvironmentOctober 31, 2019
Ka Chun ChongAyako Sumi
1
Acta Neuropathologica Communications

Alzheimer's disease tau is a prominent pathology in LRRK2 Parkinson's disease

Acta Neuropathologica CommunicationsNovember 16, 2019
Michael X HendersonVirginia M Y- Lee
15
Nihon yakurigaku zasshi. Folia pharmacologica Japonica

Development of therapeutic vaccine for life style-related diseases

Nihon yakurigaku zasshi. Folia pharmacologica JaponicaJanuary 1, 2019
Hironori Nakagami
Annals of Neurology

Midlife atherosclerosis and development of Alzheimer's or vascular dementia

Annals of NeurologyNovember 12, 2019
Anna-Märta GustavssonOskar Hansson
15
2
ACS Omega

Photoexcited Toluidine Blue Inhibits Tau Aggregation in Alzheimer's Disease

ACS OmegaNovember 12, 2019
Tushar DubeySubashchandrabose Chinnathambi
Environmental Research

A possible relationship between telomere length and markers of neurodegeneration in rat brain after welding fume inhalation exposure

Environmental ResearchNovember 5, 2019
Mohammad ShoebJames M Antonini
3
Acta Neuropathologica Communications

N368-Tau fragments generated by legumain are detected only in trace amount in the insoluble Tau aggregates isolated from AD brain

Acta Neuropathologica CommunicationsNovember 13, 2019
Kerstin SchlegelLaura Gasparini
Neurobiology of Aging

What are the threats to successful brain and cognitive aging?

Neurobiology of AgingNovember 1, 2019
Michela GallagherPeter R Rapp
Biochimica Et Biophysica Acta. General Subjects

Melatonin interacts with repeat domain of Tau to mediate disaggregation of paired helical filaments

Biochimica Et Biophysica Acta. General SubjectsNovember 9, 2019
Abhishek Ankur BalmikSubashchandrabose Chinnathambi
1

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2019 Meta ULC. All rights reserved
/feed-previews/tau-aggregation-genomics/dd022db5-6b6e-48b7-a623-82e481dc12ef